Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL796P is a non-functional pseudogene derived from the RNA, 7SL gene, which encodes the 7SL RNA component of the signal recognition particle complex. The canonical 7SL RNA is essential for targeting nascent polypeptides to the membrane during protein synthesis, but RN7SL796P neither encodes for functional RNA nor is part of active SRP machinery. It represents a genomic remnant without coding potential or established biological/disease relevance[1][4][2]. Pseudogenes are typically classified as non-coding genetic elements that resemble known genes but have lost protein-coding ability due to mutations, deletions, or lack of regulatory sequences[2]. Some pseudogenes can act as competitive regulators of microRNAs or RNA-binding proteins in specific cases; however, there is no evidence that RN7SL796P exhibits such regulatory roles[2]. If structured information on a bona fide target is needed for drug development or signaling, the focus should shift to the functional RNA, 7SL (RN7SL1) gene[3][5][6], not to this pseudogene.
None. No drugs act on this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 796, pseudogene (RN7SL796P).